Clinical Trial Update: Evaluate the Effect of Bone Marrow Derived Cd133+ Cells in Patient With Osteonecrosis of Femoral Head [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating bone marrow-derived CD133+ cells for osteonecrosis of the femoral head; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis of the Femoral Head

Drugs mentioned

• Bone marrow-derived CD133+ cells (CD133+ cell therapy)

Snippet

Sponsor: Royan Institute | Conditions: Osteonecrosis | Phase 1 | Status: COMPLETED